Literature DB >> 24512137

General statistical framework for quantitative proteomics by stable isotope labeling.

Pedro Navarro1, Marco Trevisan-Herraz, Elena Bonzon-Kulichenko, Estefanía Núñez, Pablo Martínez-Acedo, Daniel Pérez-Hernández, Inmaculada Jorge, Raquel Mesa, Enrique Calvo, Montserrat Carrascal, María Luisa Hernáez, Fernando García, José Antonio Bárcena, Keith Ashman, Joaquín Abian, Concha Gil, Juan Miguel Redondo, Jesús Vázquez.   

Abstract

The combination of stable isotope labeling (SIL) with mass spectrometry (MS) allows comparison of the abundance of thousands of proteins in complex mixtures. However, interpretation of the large data sets generated by these techniques remains a challenge because appropriate statistical standards are lacking. Here, we present a generally applicable model that accurately explains the behavior of data obtained using current SIL approaches, including (18)O, iTRAQ, and SILAC labeling, and different MS instruments. The model decomposes the total technical variance into the spectral, peptide, and protein variance components, and its general validity was demonstrated by confronting 48 experimental distributions against 18 different null hypotheses. In addition to its general applicability, the performance of the algorithm was at least similar than that of other existing methods. The model also provides a general framework to integrate quantitative and error information fully, allowing a comparative analysis of the results obtained from different SIL experiments. The model was applied to the global analysis of protein alterations induced by low H₂O₂ concentrations in yeast, demonstrating the increased statistical power that may be achieved by rigorous data integration. Our results highlight the importance of establishing an adequate and validated statistical framework for the analysis of high-throughput data.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24512137     DOI: 10.1021/pr4006958

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  61 in total

1.  QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues.

Authors:  Harsha P Gunawardena; Jonathon O'Brien; John A Wrobel; Ling Xie; Sherri R Davies; Shunqiang Li; Matthew J Ellis; Bahjat F Qaqish; Xian Chen
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

2.  Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.

Authors:  Carmen Fiuza-Luces; Alejandro Santos-Lozano; Francisco Llavero; Rocío Campo; Gisela Nogales-Gadea; Jorge Díez-Bermejo; Carlos Baladrón; África González-Murillo; Joaquín Arenas; Miguel A Martín; Antoni L Andreu; Tomàs Pinós; Beatriz G Gálvez; Juan A López; Jesús Vázquez; José L Zugaza; Alejandro Lucia
Journal:  J Physiol       Date:  2018-02-14       Impact factor: 5.182

3.  A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative Proteomics.

Authors:  Fernando García-Marqués; Marco Trevisan-Herraz; Sara Martínez-Martínez; Emilio Camafeita; Inmaculada Jorge; Juan Antonio Lopez; Nerea Méndez-Barbero; Simón Méndez-Ferrer; Miguel Angel Del Pozo; Borja Ibáñez; Vicente Andrés; Francisco Sánchez-Madrid; Juan Miguel Redondo; Elena Bonzon-Kulichenko; Jesús Vázquez
Journal:  Mol Cell Proteomics       Date:  2016-02-18       Impact factor: 5.911

4.  Exosomes promote restoration after an experimental animal model of intracerebral hemorrhage.

Authors:  Laura Otero-Ortega; Mari Carmen Gómez de Frutos; Fernando Laso-García; Berta Rodríguez-Frutos; Esperanza Medina-Gutiérrez; Juan Antonio López; Jesús Vázquez; Exuperio Díez-Tejedor; María Gutiérrez-Fernández
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-19       Impact factor: 6.200

5.  Protein signatures to distinguish aggressive from indolent prostate cancer.

Authors:  Fernando Garcia-Marques; Shiqin Liu; Sarah M Totten; Abel Bermudez; Cheylene Tanimoto; En-Chi Hsu; Rosalie Nolley; Amy Hembree; Tanya Stoyanova; James D Brooks; Sharon J Pitteri
Journal:  Prostate       Date:  2022-01-31       Impact factor: 4.104

6.  Lactate Dehydrogenase Predicts Early Hematoma Expansion and Poor Outcomes in Intracerebral Hemorrhage Patients.

Authors:  Heling Chu; Chuyi Huang; Jing Dong; Xiaobo Yang; Jun Xiang; Qiang Dong; Yuping Tang
Journal:  Transl Stroke Res       Date:  2019-01-31       Impact factor: 6.829

7.  18O proteomics reveal increased human apolipoprotein CIII in Hispanic HIV-1+ women with HAART that use cocaine.

Authors:  Frances Zenón; Inmaculada Jorge; Ailed Cruz; Erick Suárez; Annabell C Segarra; Jesús Vázquez; Loyda M Meléndez; Horacio Serrano
Journal:  Proteomics Clin Appl       Date:  2015-11-19       Impact factor: 3.494

8.  NOTCH Activation Promotes Valve Formation by Regulating the Endocardial Secretome.

Authors:  Rebeca Torregrosa-Carrión; Luis Luna-Zurita; Fernando García-Marqués; Gaetano D'Amato; Rebeca Piñeiro-Sabarís; Elena Bonzón-Kulichenko; Jesús Vázquez; José Luis de la Pompa
Journal:  Mol Cell Proteomics       Date:  2019-06-27       Impact factor: 5.911

9.  Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO.

Authors:  Andrea de la Fuente-Alonso; Marta Toral; Alvaro Alfayate; María Jesús Ruiz-Rodríguez; Elena Bonzón-Kulichenko; Gisela Teixido-Tura; Sara Martínez-Martínez; María José Méndez-Olivares; Dolores López-Maderuelo; Ileana González-Valdés; Eusebio Garcia-Izquierdo; Susana Mingo; Carlos E Martín; Laura Muiño-Mosquera; Julie De Backer; J Francisco Nistal; Alberto Forteza; Arturo Evangelista; Jesús Vázquez; Miguel R Campanero; Juan Miguel Redondo
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

10.  Plectin is a regulator of prostate cancer growth and metastasis.

Authors:  Mark Buckup; Meghan A Rice; En-Chi Hsu; Fernando Garcia-Marques; Shiqin Liu; Merve Aslan; Abel Bermudez; Jiaoti Huang; Sharon J Pitteri; Tanya Stoyanova
Journal:  Oncogene       Date:  2020-11-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.